You are here

The Effects of an NR2B NMDA Antagonist, CP-101,606, in Patients With Parkinson's Disease

Last updated on February 23, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Portland, Oregon, 97239 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Parkinson's Disease
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
30-80 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- 30- 80-year-old PD patients (UK Parkinson's Disease Brain Bank criteria) with a Hoehn
& Yahr stage score of 2-5 in the "off" state.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Subjects with evidence or history of clinically significant hematological, renal,
endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric,
neurologic, or allergic disease (including drug allergies, but excluding untreated,
asymptomatic, seasonal allergies at time of dosing).

NCT00163085
Pfizer
Completed
The Effects of an NR2B NMDA Antagonist, CP-101,606, in Patients With Parkinson's Disease

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Parkinson's Disease
NCT00163085
All Genders
30+
Years
Portland, Oregon
Parkinson's Disease With Motor Fluctuations
NCT03185481
All Genders
40+
Years
Multiple Sites
Idiopathic Parkinson's Disease
NCT02565628
All Genders
0+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now